CytoMed Therapeutics Ltd
GDTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001873093
In the last 90 days, CytoMed Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; 3 institutions reported holding it in 13F filings for Q2 2026, worth $12.2K in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding CytoMed Therapeutics Ltd changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 5 | 3 | −2 |
| Shares | 53.1K | 16.3K | −36.8K (−69.2%) |
| Value | $70.8K | $16.3K | −$54.4K (−76.9%) |
New holders (1)
Institutions that held CytoMed Therapeutics Ltd at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 10,136 | $10.1K | 0.00% |
Sold out (3)
Institutions that held CytoMed Therapeutics Ltd at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Susquehanna International Group, LLP | 29,829 | $39.7K |
| Two Sigma Securities, LLC | 11,857 | $15.8K |
| StoneX Group Inc. | 10,356 | $13.8K |